Vice President, Clinical Development

Vice President, Clinical Development About Servier Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical organization launched by the Servier Group in 2018. As a privately held, patient‑focused company, Servier is uniquely positioned to pursue innovative science, accelerate transformative therapies, and advance treatments in underserved areas of oncology. Our agile structure and global footprint enable us to make bold strategic decisions in service of patients worldwide. Role Summary Servier is seeking a highly experienced and visionary clinical development leader to join its global Oncology Clinical Development Leadership Team. Reporting to the Global Head of Oncology Clinical Development, the Vice President, Oncology, Clinical Development will play a pivotal leadership role during a period of significant organizational growth and transformation. The Vice President will provide enterprise-level leadership for a substantial portion of Servier’s oncology portfolio within an evolving, integrated development model. Programs may transition responsibility at Proof of Clinical Concept (POCC) or be advanced seamlessly from first‑in‑human (FIH) through registration. In addition to portfolio leadership, this role carries shared accountability for defining, directing, and continuously improving the scientific strategy, operating model, and performance of the global oncology development organization. This role is expected to assume delegated authority for selected global and enterprise responsibilities from the Global Head of Oncology Clinical Development, requiring seasoned judgment, operational maturity, and the ability to drive complex decision‑making in a highly matrixed environment. Key Responsibilities Enterprise & Strategic Leadership Direct clinical development strategy for a significant portion of the oncology portfolio, with primary focus on adult solid tumors and strategic input across the broader oncology pipeline. Serve as a core member of the Oncology Clinical Development Leadership Team with joint responsibility for portfolio prioritization, business development advice, and development governance. Represent Oncology Clinical Development at senior global governance forums and act as a designated delegate for the Global Head in executive decision‑making bodies, as appropriate. Provide enterprise-level leadership in areas such as operational excellence, portfolio‑wide development standards, and continuous improvement of decision‑making frameworks. Clinical Development Excellence Provide executive oversight for end‑to‑end clinical development programs, from early clinical planning through late‑stage development, registration, and lifecycle management. Ensure high scientific and ethical standards across all clinical activities, including protocol design, safety oversight, data interpretation, and regulatory submissions. Apply seasoned clinical judgment to complex program, portfolio, and risk‑benefit decisions at key development inflection points. Cross‑Functional & Global Collaboration Lead effectively within a highly matrixed, global organization, partnering across research, translational medicine, regulatory, safety, operations, commercial, and alliance teams. Drive alignment and continuity across early and late development activities, supporting Servier’s integrated oncology development model. Build strong partnerships with global key opinion leaders, academic investigators, and external collaborators to support strategic objectives. Organizational Leadership & Capability Building Lead and develop senior clinical development leaders, physicians, and scientists, with accountability for building sustainable organizational capability and succession. Set expectations and standards for leadership behaviors, talent development, and scientific excellence across the global clinical organization. Contribute to broader enterprise initiatives focused on leadership development, organizational effectiveness, and culture. Education & Required Experience M.D. or equivalent medical degree. Board Certification or Eligibility in Oncology (Medical Oncology preferred). 12+ years of progressive experience in oncology drug development with 5+ years in mid‑large pharma, including substantial late‑stage and registrational leadership. Demonstrated track record of enterprise‑level leadership, sound clinical judgment, and effective decision‑making across complex portfolios. Deep expertise in adult solid tumors; broader oncology experience, including hematologic malignancies, is desirable. Proven success operating in a global, highly matrixed environment with significant cross‑functional influence. Experience representing clinical development at senior governance forums and engaging with health authorities is strongly preferred. Travel & Location Up to 20% travel (domestic and international). Boston‑based hybrid role (2–3 days/week in the Boston Seaport office). Servier’s Commitment Servier is committed to fostering an environment of diversity, equity, and inclusion. We welcome applicants who are passionate, experienced, and innovative—even if their background doesn’t perfectly match every qualification listed. All qualified applicants will receive consideration without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status. Salary Range The salary range for this role is $342,000 - $433,000. An employee’s pay position within the salary range will be based on several factors including, but not limited to, relevant education, qualifications, certifications, experience, skills, geographic location, performance, and business or organizational needs. Employees in this position are also eligible for Short‑Term and Long‑Term incentive programs. Servier also offers a competitive and comprehensive benefits package that includes medical, dental, vision, flexible time off, 401(k), life and disability insurance, and other benefits (all benefits are subject to eligibility requirements). #J-18808-Ljbffr Servier Group